Yu MK - Search Results

1

Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.

Yu MK, Lee DY, Kim YS, Park K, Park SA, Son DH, Lee GY, Nam JH, Kim SY, Kim IS, Park RW, Byun Y. Yu MK, et al. Pharm Res. 2007 Apr;24(4):705-14. doi: 10.1007/s11095-006-9190-3. Epub 2007 Feb 21. Pharm Res. 2007. PMID: 17318418

2

Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity.

Park K, Lee GY, Kim YS, Yu M, Park RW, Kim IS, Kim SY, Byun Y. Park K, et al. J Control Release. 2006 Sep 12;114(3):300-6. doi: 10.1016/j.jconrel.2006.05.017. Epub 2006 May 25. J Control Release. 2006. PMID: 16884806

3

Conjugated chitosan as a novel platform for oral delivery of paclitaxel.

Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY, Jon S. Lee E, et al. J Med Chem. 2008 Oct 23;51(20):6442-9. doi: 10.1021/jm800767c. Epub 2008 Oct 1. J Med Chem. 2008. PMID: 18826299

4

A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex.

Bagalkot V, Lee IH, Yu MK, Lee E, Park S, Lee JH, Jon S. Bagalkot V, et al. Among authors: yu mk. Mol Pharm. 2009 May-Jun;6(3):1019-28. doi: 10.1021/mp800177f. Mol Pharm. 2009. PMID: 19338265

5

A duplex oligodeoxynucleotide-dendrimer bioconjugate as a novel delivery vehicle for doxorubicin in in vivo cancer therapy.

Lee IH, Yu MK, Kim IH, Lee JH, Park TG, Jon S. Lee IH, et al. Among authors: yu mk. J Control Release. 2011 Oct 10;155(1):88-95. doi: 10.1016/j.jconrel.2010.09.008. Epub 2010 Sep 17. J Control Release. 2011. PMID: 20854858

6

Hyper-cell-permeable micelles as a drug delivery carrier for effective cancer therapy.

Saw PE, Yu M, Choi M, Lee E, Jon S, Farokhzad OC. Saw PE, et al. Biomaterials. 2017 Apr;123:118-126. doi: 10.1016/j.biomaterials.2017.01.040. Epub 2017 Jan 31. Biomaterials. 2017. PMID: 28167390

7

Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.

Yu MK, Jeong YY, Park J, Park S, Kim JW, Min JJ, Kim K, Jon S. Yu MK, et al. Angew Chem Int Ed Engl. 2008;47(29):5362-5. doi: 10.1002/anie.200800857. Angew Chem Int Ed Engl. 2008. PMID: 18551493 No abstract available.

8

Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.

Yu MK, Park J, Jeong YY, Moon WK, Jon S. Yu MK, et al. Nanotechnology. 2010 Oct 15;21(41):415102. doi: 10.1088/0957-4484/21/41/415102. Epub 2010 Sep 17. Nanotechnology. 2010. PMID: 20852354

9

Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.

Lee IH, An S, Yu MK, Kwon HK, Im SH, Jon S. Lee IH, et al. Among authors: yu mk. J Control Release. 2011 Nov 7;155(3):435-41. doi: 10.1016/j.jconrel.2011.05.025. Epub 2011 May 27. J Control Release. 2011. PMID: 21641946

10

MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles.

Lee HJ, Nguyen YT, Muthiah M, Vu-Quang H, Namgung R, Kim WJ, Yu MK, Jon S, Lee IK, Jeong YY, Park IK. Lee HJ, et al. Among authors: yu mk. J Biomed Nanotechnol. 2012 Jun;8(3):361-71. doi: 10.1166/jbn.2012.1407. J Biomed Nanotechnol. 2012. PMID: 22764405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters